Fischer Medical Ventures Ltd

Fischer Medical Ventures announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 0.05 per equity Share (i.e. 0.5%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Fischer Medical Ventures declined 42.08% to Rs 1.50 crore in the quarter ended March 2025 as against Rs 2.59 crore during the previous quarter ended March 2024. Sales rose 136.51% to Rs 49.17 crore in the quarter ended March 2025 as against Rs 20.79 crore during the previous quarter ended March 2024. For the full year,net profit declined 20.11% to Rs 1.47 crore in the year ended March 2025 as against Rs 1.84 crore during the previous year ended March 2024. Sales rose 427.65% to Rs 110.70 crore in the year ended March 2025 as against Rs 20.98 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales49.1720.79 137 110.7020.98 428 OPM %4.8812.12 -2.568.87 - PBDT2.322.93 -21 3.862.29 69 PBT1.812.75 -34 2.222.11 5 NP1.502.59 -42 1.471.84 -20 Powered by Capital Market - Live

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 26 March 2025.Powered by Capital Market - Live

Net profit of Fischer Medical Ventures reported to Rs 0.20 crore in the quarter ended December 2024 as against net loss of Rs 0.13 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

Time Medical International Ventures (India) has become the first Magnetic Resonance Imaging (MRI) manufacturer in India to receive the official license to manufacture for sale or distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the CDSCO. With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: EMMA - 1.5T MRI Scanner, PICA - 0.35T MRI Scanner, MICA - 1.5T MRI Scanner and QUIN - 1.5T MRI Scanner. The EMMA, MICA, and QUIN MRI systems are 1.5T MRI scanners, offering exceptional imaging resolution and precision for a wide range of clinical applications, while the PICA model is a 0.35T MRI scanner, tailored for specific diagnostic needs. These models are available for distribution across India, helping to address the growing demand for reliable and advanced medical imaging solutions. We are thrilled to be the first Make in India company to receive the CDSCO license for the manufacturing and distribution of MRI systems. This achievement demonstrates the strength and potential of India's medical device manufacturing sector. With our EMMA, PICA, MICA, and QUIN MRI systems, we are committed to providing hospitals and diagnostic centers with cutting-edge, affordable diagnostic imaging solutions,' said the Management Team of Fischer Medical Ventures. Fischer Medical Ventures has changed the nature of Business from Manufacturing of Chemicals to Trading and Manufacturing of Medical equipment including MRI machines consequent to share subscription agreement. The company reported consolidated net profit of Rs 0.29 crore in Q2 FY25 as against net loss of Rs 0.12 crore in Q1 FY25. Net sales surged 291.9% YoY to Rs 39.66 crore in the September 2024 quarter. Powered by Capital Market - Live

Fischer Medical Ventures announced that its wholly owned subsidiary, Time Medical International Ventures (India) has become the first indigenous MRI manufacturer in India to receive the official License to Manufacture for Sale or Distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the Central Drugs Standard Control Organization (CDSCO). This achievement marks a significant milestone in the Make in India initiative, reinforcing the company''s commitment to developing high-quality, locally manufactured medical devices that meet international standards. With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: 'h EMMA - 1.5T MRI Scanner 'h PICA - 0.35T MRI Scanner 'h MICA - 1.5T MRI Scanner 'h QUIN - 1.5T MRI ScannerPowered by Capital Market - Live

Fischer Medical Ventures announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 January 2025.Powered by Capital Market - Live

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 3 January 2025.Powered by Capital Market - Live